AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 30.18 |
Market Cap | 1.53B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 1.3 |
PE Ratio (ttm) | 24 |
Forward PE | n/a |
Analyst | Buy |
Ask | 44.37 |
Volume | 258,209 |
Avg. Volume (20D) | 307,432 |
Open | 30.10 |
Previous Close | 30.28 |
Day's Range | 29.49 - 31.35 |
52-Week Range | 29.08 - 63.20 |
Beta | undefined |
About ASTH
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver...
Analyst Forecast
According to 6 analyst ratings, the average rating for ASTH stock is "Buy." The 12-month stock price forecast is $63, which is an increase of 101.92% from the latest price.
Next Earnings Release
Analysts project revenue of $613.01M, reflecting a 73.64% YoY growth and earnings per share of 0.09, making a -65.38% decrease YoY.